What Needs To Be True To Buy Twist Bioscience Stock Now?
Codexis Inc CDXS
$1.32
▼ -3.65%
($-0.05)
⬇️ Below Yest. Low
🎢 High Beta
Open
$1.38
Prev Close
$1.37
Day Range
$1.32 – $1.40
52W Range
$0.96 – $2.98
Market Cap
$144.55M
Beta
2.36
EPS (TTM)
$-0.34
📋 Company Profile
| Industry | Life Sciences Tools & Services |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2010-04-22 |
| Shares Out. | 107,560,000 |
| Website | codexis.com/ ↗ |
| Phone | 16504218100 |
| Employees | 146 |
| Revenue | $14.9M |
| Gross Profit | $11.4M |
| Net Income | -$12.0M |
| Free Cash Flow | -$12.2M |
| Total Assets | $120.1M |
| Total Liabilities | $87.1M |
| Equity | $33.0M |
About Codexis Inc
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Codexis Inc is a publicly traded company under the ticker symbol CDXS on the NASDAQ NMS - GLOBAL MARKET, operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-09-01)